Literature DB >> 861911

Immunoblastic lymphadenopathy: case report and literature review.

A A Cooperberg, M B de Champlain, J Siminovitch, A Rosenberg, J P Schwartz.   

Abstract

A patient with immunoblastic lymphadenopathy (IL) had an unusual course of illness, with frequent episodes, over a 20-month period, of chills, fever, abdominal pain, hepatosplenomegaly and weight loss. The episodes were short-lived and many resolved spontaneously. Eventually generalized lymphadenopathy and profound monoclonal IgG gammopathy developed, with atypical mononuclear cells in the peripheral blood and increased numbers of plasmacytoid cells in the bone marrow. Lymph node biopsy revealed the morphologic triad typical of IL: proliferation immunoblasts, proliferation of small blood vessels and the deposit of an amorphous acidophillic material in the vascular walls and the interstitium. Up to October 1976 110 cases had been reported of this disorder, first described 3 years ago, which indicates that IL is not rare. Remissions have occurred spontaneously and after steroid therapy or chemotherapy or both. However, death has been reported in almost 50% of the cases, and the best approach to therapy remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 861911      PMCID: PMC1879602     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  11 in total

1.  Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease.

Authors:  R J Lukes; B H Tindle
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

2.  [Angio-immunoblastic lymphatic disease with dysproteinemia].

Authors:  G Sébahoun; N Gratecos; J Foa; D Sainty; P Lefèvre; Y Carcassonne
Journal:  Nouv Presse Med       Date:  1976-01-24

3.  [Angioimmunoblastic adenopathies].

Authors:  G Mathé; J L Amiel; R Gérard-Marchant; B Caillou; J L Pico; D Machover
Journal:  Nouv Presse Med       Date:  1976-06-12

4.  Letter: Angio-immunoblastic lymphadenopathy with dysproteinaemia.

Authors:  C H Horne; R A Fraser; J C Petrie
Journal:  Lancet       Date:  1974-08-03       Impact factor: 79.321

5.  Angio-immunoblastic lymphadenopathy with dysproteinaemia.

Authors:  G Frizzera; E M Moran; H Rappaport
Journal:  Lancet       Date:  1974-06-01       Impact factor: 79.321

6.  Letter: Levamisole in angio-immunoblastic lymphadenopathy.

Authors:  J Bensa; J Faure; H Martin; J Sotto; R Schaerer
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

7.  Angioimmunoblastic lymphadenopathy.

Authors:  S B Moor; E G Harrison; L H Weiland
Journal:  Mayo Clin Proc       Date:  1976-05       Impact factor: 7.616

8.  Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course.

Authors:  G Frizzera; E M Moran; H Rappaport
Journal:  Am J Med       Date:  1975-12       Impact factor: 4.965

9.  Immunoblastic lymphadenopathy. A report of two cases.

Authors:  M J Kalus
Journal:  Arch Pathol Lab Med       Date:  1976-09       Impact factor: 5.534

10.  Restoration of defective cellular immunity by levamisole in a patient with immunoblastic lymphadenopathy.

Authors:  J Ellegaard; A M Boesen
Journal:  Scand J Haematol       Date:  1976-07
View more
  2 in total

1.  Rapidly fatal respiratory failure and angioimmunoblastic lymphadenopathy: possible contributions of immunoblastic leukaemia, chemotherapy, and multiple antibodies directed against mature blood cells.

Authors:  P M Trenchard; J A Whittaker; J Gough; H Parry
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

2.  Angioimmunoblastic lymphadenopathy associated with polyarthritis.

Authors:  R S Rothwell; M J Mant; P Davis
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.